Oral administration of interferon tau enhances oxidation of energy substrates and reduces adiposity in Zucker diabetic fatty rats

BioFactors

Volumn 39, Issue 5, 2013, Pages 552-563

  Tekwe, Carmen D ^a   Lei, Jian ^a   Yao, Kang ^a   Rezaei, Reza ^a   Li, Xilong ^a   Dahanayaka, Sudath ^a   Carroll, Raymond J ^a   Meininger, Cynthia J ^b   Bazer, Fuller W ^a   Wu, Guoyao ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Diabetes; Energy expenditure; Interferon tau; Obesity; Tissue oxidation

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; GLUTATHIONE; GLUTATHIONE DISULFIDE; KETONE BODY; LEUCINE; OLEIC ACID; TAU INTERFERON; TETRAHYDROBIOPTERIN; TRIACYLGLYCEROL;

ABDOMINAL FAT; AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENERGY EXPENDITURE; FATTY ACID BLOOD LEVEL; FATTY LIVER; FLUID INTAKE; FOOD INTAKE; GLUCOSE URINE LEVEL; LIPOLYSIS; LIVER WEIGHT; LOW DRUG DOSE; MALE; NONHUMAN; OBESITY; OXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SKELETAL MUSCLE; THERMOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE; ZUCKER DIABETIC FATTY RAT;

DIABETES; ENERGY EXPENDITURE; INTERFERON TAU; OBESITY; TISSUE OXIDATION;

ADIPONECTIN; ADIPOSE TISSUE, WHITE; ADIPOSITY; ADMINISTRATION, ORAL; AMINO ACIDS; ANIMALS; ANTI-OBESITY AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG EVALUATION, PRECLINICAL; ENERGY METABOLISM; GLYCEROL; INSULIN; INTERFERON TYPE I; LEPTIN; LEUCINE TRANSAMINASE; LIPIDS; LIVER; MALE; OBESITY; ORGAN SIZE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PREGNANCY PROTEINS; RATS; RATS, ZUCKER;

EID: 84886389964     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1113     Document Type: Article

References (49)

1. Hill, J. O., Wyatt, H. R., Reed, G. W., and Peters, J. C. (2003) Obesity and the environment: where do we go from here? Science 299, 853-855.
2. Jobgen, W. S., Fried, S. K., Fu, W. J., Meininger, C. J., and Wu, G. (2006) Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J. Nutr. Biochem. 17, 571-588.
3. Abelson, P. and Kennedy, D. (2004) The obesity epidemic. Science 304, 1413.
4. Mokdad, A. H., Marks, J. S., Stroup, D. F., and Gerberding, J. L. (2004) Actual causes of death in the United States, 2000. JAMA 291, 1238-1245.
5. Finkelstein, E. A., Fielborn, I. C., and Wang G. (2004) State-level estimates of annual medical expenditures attributable to obesity. Obesity Res. 12, 18-24.
6. Endocrine Society. (2010) ObesityinAmerica.org.
7. WHO. (2012) Available at: http://www.who.int/mediacentre/factsheets/fs311/en/index.html. Accessed on November 16, 2012.
8. Fernandez-Sanchez, A., Madrigal-Santillán, E., Bautista, M., Esquivel-Soto, J., Morales-González, A., et al. (2011) Inflammation, oxidative stress and obesity. Int. J. Mol. Sci. 12, 3117-3132.
9. Levine, J. A., Lanningham-Foster, L. M., McCrady, S. K., Krizan, A. C., Olson, L. R., et al. (2005) Interindividual variation in posture allocation: possible role in human obesity. Science 307, 584-586.
10. Dandona, P., Aljada, A., and Bandyopadhay, A. (2004) Inflammation: the link between insulinresistance, obesity and diabetes. Trends Immunol. 25, 4-7.
11. Martal, J., Lacroix, M. C., Loudes, C., Saunier, M., and Winterberger-Torres, S. (1979) Trophoblastin, an antiluteolytic protein present in early pregnancy in sheep. J. Reprod. Fertil. 56, 63-73.
12. Bazer, F. W. and Johnson, H. M. (1991) Type I conceptus interferons: maternal recognition of pregnancy signals and potential therapeutic agents. Am. J. Reprod. Immun. 26, 19-22.
13. Pontzer, C. H., Torres, B. A., Vallet, J. L., Bazer, F. W., and Johnson H. M. (1988) Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1. Biochem. Biophys. Res. Commun. 152, 801-807.
14. Pontzer, C. H., Bazer, F. W., and Johnson, H. M. (1991) Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. Cancer Res. 51, 5304-5307.
15. Soos, J. M., Subramaniam, P. S., Hobeika, A. C., Schiffenbauer, J., and Johnson, H. M. (1995) The IFN pregnancy recognition hormone IFN τ blocks both developmental and superantigen reaction of experimental allergic encephalomyelitis without associated toxicity. J. Immunol. 155, 2747-2753.
16. Soos, J. M., Mujtaba, M. G., Subramaniam, P. S., Streit, W. J., and Johnson, H. M. (1997) Oral feeding of interferon τ can prevent acute forms of experimental allergic encephalomyelitis. J. Neuroimmunol. 75, 43-50.
17. Sobel, D. O., Ahvazi, B., Amjad, F., Mitnaul, L., and Pontzer, C. (2008) Interferon-tau inhibits the development of diabetes in NOD mice. Autoimmunity 41, 543-553.
18. Bazer, F. W., Kim, J., Song, G., Ka, H., Tekwe, C. D., and Wu, G. (2012) Select nutrients, progesterone, and interferon tau affect conceptus metabolism and development. Ann. N.Y. Acad. Sci. 1271, 88-96.
19. Ruth, M. R., Taylor, C. G., Zahradka, P., and Field, C. J. (2008) Abnormal immune responses in fa/fa Zucker rats and effects of feeding conjugated linoleic acid. Obesity (Silver Spring) 16, 1770-1779.
20. Wijekoon, E. P., Hall, B., Ratnam, S., Brosnan, M. E., Zeisel, S. H., and Brosnan, J. T. (2005) Homocysteine metabolism in ZDF (type 2) diabetic rats. Diabetes 54, 3245-3251.
21. Fu, W.J., Haynes, T.E., Kohli, R., Hu, J., Shi, W., et al. (2005) Dietary L-arginine supplementation reduces fat mass in Zucker Diabetic Fatty rats. J. Nutr. 135, 714-721.
22. VanHeeke, G., Ott, T. L., Strauss, A., Ammaturo, D., and Bazer, F. B. (1996) High yield expression and secretion of the pregnancy recognition hormone ovine interferon-τ by Pichia pastoris. J. Interferon Res.16, 119-126.
23. G-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat. Diabetes 44, 360-364.
24. Jobgen, W. J., Meininger, C. J., Jobgen, S. C., Li, P., Lee, M.-J., et al. (2009) Dietary L-arginine supplementation reduces white-fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats. J. Nutr. 139, 230-237.
25. Meininger, C. J. and Wu, G. (2002) Regulation of endothelial cell proliferation by nitric oxide. Methods Enzymol. 352, 280-295.
26. Wu, G. and Thompson, J. R. (1987) Ketone bodies inhibit leucine degradation in chick skeletal muscle. Int. J. Biochem. 19, 937-943.
27. Wu, G., Collins, J. K., Perkins-Veazie, P., Siddiq, M., Dolan, K. D., et al. (2007) Dietary supplementation with watermelon pomace juice enhances arginine availability andameliorates the metabolic syndrome in Zucker diabetic fatty rats. J. Nutr. 137, 2680-2685.
28. Wu, G., Field, C. J., and Marliss, E. B. (1991) Glucose and glutamine metabolism in rat macrophages: enhanced glycolysis and unaltered glutaminolysis in spontaneously diabetic BB rats. Biochim. Biophys. Acta 1115, 166-173.
29. Littel, R., Milliken, G., and Stroup, W. (1996) System for Mixed Models. SAS Institute, Cary, N.C.
30. Wei, J. W., Carroll, R. J., Harden, K. K., and Wu, G. (2012) Comparisons of treatment means when factors do not interact in two-factorial studies. Amino Acids 42, 2031-2035.
31. Kakuma, T., Lee, Y., Higa, M., Wang, Z. W., Pan, W., et al. (2000) Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc. Natl. Acad. Sci. USA 97, 8536-8541.
32. Peterson, R. G., Little, L. A., and Neel, M. A. (1990) Zucker diabetic fatty rats as a model for non-insulin-dependent diabetes mellitus. ILAR J. 32.
33. Oltman, C. L., Davidson, E. P., Coppey, L. J., Kleinschmidt, T. L., and Yorek, M. A. (2009) Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction. Diabetes Obes. Metab. 11, 223-233.
34. Satterfield, M. C. and Wu, G. (2011) Growth and development of brown adipose tissue: significance and nutritional regulation. Front. Biosci. 16, 1589-1608.
35. Cannon, B. and Nedergaard, J. (2004) Brown adipose tissue: function and physiological significance. Physiol. Rev. 84, 277-359.
36. Yoneshiro, S., Aita, S., Matsushita, M., Kameya, T., Nakada, K., et al. (2011) Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men. Obesity (Silver Spring) 19, 13-16.
37. Nedergaard, J., Bengtsson, T., and Cannon, B. (2007) Unexpected evidence for active brownadipose tissue in adult humans. Am. J. Physiol. Endocrinol. Metab. 293, E444-452.
38. Kajimura, S., Seale, P., and Spiegelman, B. M. (2010) Transcriptional control of brown fat development. Cell Metab. 11, 257-262.
39. Marliss, E. B., Chevalier, S., Gougeon, R., Morais, J. A., Lamarche, M., et al. (2006) Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover. Diabetologia 49, 351-359.
40. Newgard, C. B. (2012) Interplay between lipids and branched-chain amino acids in developmentof insulin resistance. Cell Metab. 15, 606-614.
41. de Heredia, F. P., Gómez-Martínez, S., and Marcos, A. (2012) Obesity, inflammation and the immune system. Proc. Nutr. Soc. 71, 332-338.
42. Shi, W., Meininger, C. J., Haynes, T. E., Hatakeyama, K., and Wu, G. (2004) Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell Biochem. Biophys. 41, 415-433.
43. Wu, G., Fang, Y. Z., Yang, S., Lupton, J. R., and Turner N. D. (2004) Glutathione metabolism and its implications for health. J. Nutr. 134, 489-492.
44. Ichikawa, M., Miyasaka, K., Fujita, Y., Shimazoe, T., and Funakoshi, A. (1998) Disappearance of diurnal rhytm of energy expenditure in genetically diabetic obese rats. Jpn. J. Physiol. 48, 211-214.
45. Yoshida, Y., Ichikawa, M., Ohta, M., Kanai, S., Kobayash, M., et al. (2002) A peroxisome proliferator-activated receptor gamma agonist influenced daily profile of energy expenditure in genetically obese diabetic rats. Jpn. J. Pharmacol. 88, 279-284.
46. Ichikawa, M., Kanai, S., Ichimani, Y., Funakoshi, A., and Miyasaka, K. (2000) The diurnal rhythm of energy expenditure differs between obese and glucose intolerant rats and Streptozotocin-induced diabetic rats. J. Nutr. 130, 2562-2567.
47. Liu, C., Li, S., Liu, T., Borjigin, J., and Lin, J. D. (2007) Transcriptional coactivator PGC-1alphaintegrates the mammalian clock and energy metabolism. Nature 447, 477-481.
48. Li, S. and Lin, J. D. (2009) Molecular control of circadian metabolic rhythms. J. Appl. Physiol. 107, 1959-1964.
49. Dai, Z. L., Wu, Z. L., Yang, Y., Wang, J. J., Satterfield, M. C., et al. (2013) Nitric oxide and energy metabolism in mammals. BioFactors, in press. DOI: 10.1002/biof.1099.